278 related articles for article (PubMed ID: 20571266)
1. Surgical treatment of pancreatic neuroendocrine tumors: report of 112 cases.
Gao C; Fu X; Pan Y; Li Q
Dig Surg; 2010 Aug; 27(3):197-204. PubMed ID: 20571266
[TBL] [Abstract][Full Text] [Related]
2. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
3. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
4. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
5. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
[TBL] [Abstract][Full Text] [Related]
8. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
[TBL] [Abstract][Full Text] [Related]
9. Surgery in malignant pancreatic neuroendocrine tumors.
Nguyen SQ; Angel LP; Divino CM; Schluender S; Warner RR
J Surg Oncol; 2007 Oct; 96(5):397-403. PubMed ID: 17469119
[TBL] [Abstract][Full Text] [Related]
10. Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?
Abu Hilal M; McPhail MJ; Zeidan BA; Jones CE; Johnson CD; Pearce NW
JOP; 2009 May; 10(3):276-9. PubMed ID: 19454819
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.
Fischer L; Kleeff J; Esposito I; Hinz U; Zimmermann A; Friess H; Büchler MW
Br J Surg; 2008 May; 95(5):627-35. PubMed ID: 18306152
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution.
Dahdaleh FS; Calva-Cerqueira D; Carr JC; Liao J; Mezhir JJ; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2012 Mar; 19(3):966-72. PubMed ID: 21845496
[TBL] [Abstract][Full Text] [Related]
13. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.
Falconi M; Zerbi A; Crippa S; Balzano G; Boninsegna L; Capitanio V; Bassi C; Di Carlo V; Pederzoli P
Ann Surg Oncol; 2010 Jun; 17(6):1621-7. PubMed ID: 20162460
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Sichinohe T
Hepatogastroenterology; 2012; 59(120):2623-6. PubMed ID: 22497945
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
Sallinen V; Haglund C; Seppänen H
Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
[TBL] [Abstract][Full Text] [Related]
16. Surgery for mucin-producing pancreatic tumor.
Yasuda H; Takada T; Amano H; Yoshida M
Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
[TBL] [Abstract][Full Text] [Related]
17. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.
Bilimoria KY; Talamonti MS; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
Ann Surg; 2008 Mar; 247(3):490-500. PubMed ID: 18376195
[TBL] [Abstract][Full Text] [Related]
18. Nonfunctioning neuroendocrine tumors of the pancreas: clinical presentation of 7 patients.
Closset J; Delhaye M; Sperduto N; Rickaert F; Gelin M
Hepatogastroenterology; 1996; 43(12):1640-4. PubMed ID: 8975980
[TBL] [Abstract][Full Text] [Related]
19. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
[TBL] [Abstract][Full Text] [Related]
20. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].
Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G
Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]